Kolltan Pharma Raises $35 Million
Kolltan Pharmaceuticals Inc., a New Haven, Conn.-based developer of oncology therapeutics, has raised over $35 million in Series A funding. No investor information was disclosed.
9 January 2009•3 mins read
Kolltan Pharmaceuticals Inc., a New Haven, Conn.-based developer of oncology therapeutics, has raised over $35 million in Series A funding. No investor information was disclosed.
